Heparan sulfate proteoglycans: heavy hitters in the angiogenesis arena.

Without new blood vessels, neoplasms cannot expand beyond a few millimeters, the point at which the diffusion of nutrients and the disposal of waste products become rate-limiting. Regulation of angiogenesis thus must be controlled at multiple levels. For instance, the VEGF family of heparin-binding proteins and their primary receptors, VEGFR-1 and VEGFR-2 (KDR), products of the flt-1 and the flk-1 gene, respectively, are required for angioblast differentiation and vasculogenesis, and specific VEGF isoforms play distinct roles in promoting endothelial growth and migration during angiogenesis. In addition, angiogenesis is profoundly affected by several members of the FGF family and their four receptors, and indeed, supplementing the media of endothelial cell cultures with basic FGF (FGF2) and heparin is now well established as a means to obtain optimal growth, migration, and capillary morphogenesis. In addition to producing proangiogenic factors, tumor cells also directly or indirectly generate negative angiogenic stimuli. The ultimate growth rate of the tumors is thus a fine balance between positive and negative angiogenic cues.

[1]  D. Mukhopadhyay,et al.  Cell surface glypicans are low-affinity endostatin receptors. , 2001, Molecular cell.

[2]  R. Iozzo,et al.  Fibroblast Growth Factor-binding Protein Is a Novel Partner for Perlecan Protein Core* , 2001, The Journal of Biological Chemistry.

[3]  N. Perrimon,et al.  Heparan sulfate proteoglycans are critical for the organization of the extracellular distribution of Wingless. , 2001, Development.

[4]  M. Ruegg,et al.  An Alternative Amino-Terminus Expressed in the Central Nervous System Converts Agrin to a Type II Transmembrane Protein , 2001, Molecular and Cellular Neuroscience.

[5]  T. Veikkola,et al.  Interaction of endostatin with integrins implicated in angiogenesis. , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[6]  David F. Burke,et al.  Crystal structure of fibroblast growth factor receptor ectodomain bound to ligand and heparin , 2000, Nature.

[7]  K. W. Kim,et al.  Endostatin inhibits endothelial and tumor cellular invasion by blocking the activation and catalytic activity of matrix metalloproteinase. , 2000, Cancer research.

[8]  J. Couchman,et al.  Still More Complexity in Mammalian Basement Membranes , 2000, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[9]  T. Sasaki,et al.  Endostatins derived from collagens XV and XVIII differ in structural and binding properties, tissue distribution and anti-angiogenic activity. , 2000, Journal of molecular biology.

[10]  J. Myers,et al.  Basement Membrane Zone Type XV Collagen Is a Disulfide-bonded Chondroitin Sulfate Proteoglycan in Human Tissues and Cultured Cells* , 2000, The Journal of Biological Chemistry.

[11]  N. Perrimon,et al.  Specificities of heparan sulphate proteoglycans in developmental processes , 2000, Nature.

[12]  J. Hassell,et al.  Heparan Sulfate Proteoglycans in Basement Membranes: Perlecan, Agrin, and Collagen XVIII , 2000 .

[13]  R. Iozzo Proteoglycans : structure, biology, and molecular interactions , 2000 .

[14]  D. Jackson,et al.  Heparan Sulfate Proteoglycan Isoforms of the CD44 Hyaluronan Receptor Induced in Human Inflammatory Macrophages Can Function as Paracrine Regulators of Fibroblast Growth Factor Action* , 2000, The Journal of Biological Chemistry.

[15]  J. Uitto,et al.  The Protein Core of the Proteoglycan Perlecan Binds Specifically to Fibroblast Growth Factor-7* , 2000, The Journal of Biological Chemistry.

[16]  M. Nugent,et al.  Potentiation and inhibition of bFGF binding by heparin: a model for regulation of cellular response. , 2000, Biochemistry.

[17]  J. Woessner,et al.  Heparan Sulfate Proteoglycans as Extracellular Docking Molecules for Matrilysin (Matrix Metalloproteinase 7)* , 2000, The Journal of Biological Chemistry.

[18]  U. Felbor,et al.  Collagen XVIII/endostatin structure and functional role in angiogenesis. , 2000, Cell structure and function.

[19]  S. Selleck,et al.  The Elusive Functions of Proteoglycans: In Vivo Veritas , 2000 .

[20]  R. Timpl,et al.  Structural basis and potential role of heparin/heparan sulfate binding to the angiogenesis inhibitor endostatin , 1999, The EMBO journal.

[21]  R. Sasisekharan,et al.  FGF‐2/fibroblast growth factor receptor/heparin‐like glycosaminoglycan interactions: a compensation model for FGF‐2 signaling , 1999, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[22]  Paul Wordsworth,et al.  Inducible Expression of the Cell Surface Heparan Sulfate Proteoglycan Syndecan-2 (Fibroglycan) on Human Activated Macrophages Can Regulate Fibroblast Growth Factor Action* , 1999, The Journal of Biological Chemistry.

[23]  I Que,et al.  Endostatin inhibits VEGF‐induced endothelial cell migration and tumor growth independently of zinc binding , 1999, The EMBO journal.

[24]  A. Friedl,et al.  Endostatin binds to blood vessels in situ independent of heparan sulfate and does not compete for fibroblast growth factor-2 binding. , 1999, The American journal of pathology.

[25]  G. Neufeld,et al.  Glypican-1 Is a VEGF165 Binding Proteoglycan That Acts as an Extracellular Chaperone for VEGF165 * , 1999, The Journal of Biological Chemistry.

[26]  M. Nugent,et al.  Antisense targeting of perlecan blocks tumor growth and angiogenesis in vivo. , 1998, The Journal of clinical investigation.

[27]  T. Sasaki,et al.  Mapping of the binding of platelet-derived growth factor to distinct domains of the basement membrane proteins BM-40 and perlecan and distinction from the BM-40 collagen-binding epitope. , 1998, European journal of biochemistry.

[28]  R. Iozzo Matrix proteoglycans: from molecular design to cellular function. , 1998, Annual review of biochemistry.

[29]  R. Iozzo,et al.  Transcriptional Silencing of Perlecan Gene Expression by Interferon-γ* , 1998, The Journal of Biological Chemistry.

[30]  D. Noonan,et al.  Suppression of invasive behavior of melanoma cells by stable expression of anti-sense perlecan cDNA. , 1997, Annals of oncology : official journal of the European Society for Medical Oncology.

[31]  R. Iozzo,et al.  Developmental expression of perlecan during murine embryogenesis , 1997, Developmental dynamics : an official publication of the American Association of Anatomists.

[32]  A. Wellstein,et al.  A secreted FGF-binding protein can serve as the angiogenic switch in human cancer , 1997, Nature Medicine.

[33]  R. Iozzo,et al.  A role for perlecan in the suppression of growth and invasion in fibrosarcoma cells. , 1997, Cancer research.

[34]  A. Admon,et al.  Identification of Glypican as a Dual Modulator of the Biological Activity of Fibroblast Growth Factors* , 1997, The Journal of Biological Chemistry.

[35]  D. Noonan,et al.  Suppression of autocrine and paracrine functions of basic fibroblast growth factor by stable expression of perlecan antisense cDNA , 1997, Molecular and cellular biology.

[36]  William Arbuthnot Sir Lane,et al.  Endostatin: An Endogenous Inhibitor of Angiogenesis and Tumor Growth , 1997, Cell.

[37]  John M. Whitelock,et al.  The Degradation of Human Endothelial Cell-derived Perlecan and Release of Bound Basic Fibroblast Growth Factor by Stromelysin, Collagenase, Plasmin, and Heparanases (*) , 1996, The Journal of Biological Chemistry.

[38]  S. E. Brodie New York, New York, USA , 1996 .

[39]  A. Yayon,et al.  Perlecan, basal lamina proteoglycan, promotes basic fibroblast growth factor-receptor binding, mitogenesis, and angiogenesis , 1994, Cell.

[40]  R. Iozzo,et al.  The biology of perlecan: the multifaceted heparan sulphate proteoglycan of basement membranes and pericellular matrices. , 1994, The Biochemical journal.

[41]  M. Kan,et al.  Characterization and molecular cloning of a putative binding protein for heparin-binding growth factors. , 1991, The Journal of biological chemistry.

[42]  P. Bioulac-Sage,et al.  Tumor progression is associated with a significant decrease in the expression of the endostatin precursor collagen XVIII in human hepatocellular carcinomas. , 2001, Cancer research.

[43]  J. Thiery,et al.  Fibroblast growth factor-2. , 2000, The international journal of biochemistry & cell biology.

[44]  M. Götte,et al.  Functions of cell surface heparan sulfate proteoglycans. , 1999, Annual review of biochemistry.

[45]  B. Olwin,et al.  [11] Regulation by heparan sulfate in fibroblast growth factor signaling , 1994 .

[46]  B. Olwin,et al.  Regulation by heparan sulfate in fibroblast growth factor signaling. , 1994, Methods in enzymology.